Sales and profits fall at Fischer

Article

Fischer Imaging chief executive Morgan Nields blamed "a radical restructuring"of theU.S. imaging equipment market for sales and profit declines in1994 for the Denver-based general radiography equipment manufacturer. Revenue for the year

Fischer Imaging chief executive Morgan Nields blamed "a radical restructuring"of theU.S. imaging equipment market for sales and profit declines in1994 for the Denver-based general radiography equipment manufacturer.

Revenue for the year ending Dec. 31, 1994, was $68.4 million,compared to $73.3 million in 1993. The company lost $5.6 millionin 1994 after reporting a break-even performance for the previousyear.

Fourth-quarter trends were also down. As revenue fell 5.6%to $18.3 million, Fischer posted a fourth-quarter loss of $980,000,compared to a profit of $462,000 for the same period of 1993.The downturn was attributed principally to delays in anticipatedoriginal equipment manufacturer shipments, caused by customer-requesteddesign changes in 1994, according to the company.

Nields linked Fischer's performance last year with an estimated30% revenue decline in $1 billion domestic diagnostic x-ray equipmentmarket in 1994.

"We believe the market is undergoing a continuing radicalrestructuring as providers and payors realign strategies in acompetitive marketplace," he said.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.